Outcomes 2006–2011 | LA | TS | p value |
---|---|---|---|
Variables after PSM | n = 60 | n = 53 | |
Euroscore II risk (%) | 3.5 (3.5–8) | 4.7 (3.5–8.5) | 0.235 |
Cross-clamp time (minutes) | 106 (61–134) | 100 (69–140) | 0.739 |
CPB time (minutes) | 123 (93–160) | 135 (96–160) | 0.372 |
ICU stay (days) | 3 (1–6) | 4 (2–10) | 0.04 |
Atrial fibrillation | 19 (31.7) | 19 (35.8) | 0.639 |
Atrial flutter | 2 (3.3) | 2 (3.8) | 1 |
Nodal rhythm | 6 (10) | 14 (26.4) | 0.023 |
AV block | 1 (1.7) | 4 (7.5) | 0.185 |
Sick sinus syndrome | 0 (0) | 0 (0) | – |
Other SV arrhythmias | 0 (0) | 4 (7.5) | 0.045 |
Antiarrhythmic medication | 17 (28.3) | 14 (26.4) | 0.82 |
Electrical cardioversion | 2 (3.3) | 4 (7.5) | 0.417 |
Device placement | 2 (3.3) | 5 (9.4) | 0.25 |
Blood transfusion | 36 (60) | 39 (73.6) | 0.127 |
Creatinine (mg/dL) | 1.3 (1.1–1.6) | 1.3 (1–1.6) | 0.666 |
Oral anticoagulation | 15 (25) | 9 (17) | 0.298 |
Perioperative mortality | 4 (6.7) | 6 (11.3) | 0.511 |
Post-discharge | |||
SV arrhythmia | 1 (1.7) | 3 (5.7) | 0.466 |
Device placement | 1 (1.7) | 3 (5.7) | 0.466 |
Stroke | 2 (3.3) | 1 (1.9) | 1 |
Valve reintervention | 3 (5) | 4 (7.5) | 0.597 |
Chronic oral anticoagulation | 15 (25) | 10 (18.9) | 0.433 |
Overall mortality | 6 (10) | 9 (17) | 0.275 |